Account
Orders
Advanced search
Louise Reader
Read on Louise Reader App.
This book discusses the potential of magnetic nanoparticles in cancer therapy. It reviews the synthesis of magnetic nanoparticles – which, due to their small size and processability, have become widely used in various biomedical applications – and their role in cancer diagnosis, drug delivery, and personalized medicine. It presents the applications of magnetic nanoparticle in the destruction of tumor cells by heating them to their apoptosis threshold.
It also introduces the new perspective in the development of magnetic field induced drug release in the cancer treatment. Importantly, the book covers the innovative three arm approach in cancer treatment by magnetic nanoparticles through inducing apoptosis, activating the immune response, and targeted-drug delivery.
It highlights various novel approaches to improve the biocompatibility, half-life, and biodegradability of magnetic nanoparticles.
In closing, the book offers comprehensive descriptions of numerous challenges involved in applying magnetic nanoparticles to cancer treatment.
Les livres numériques peuvent être téléchargés depuis l'ebookstore Numilog ou directement depuis une tablette ou smartphone.
PDF : format reprenant la maquette originale du livre ; lecture recommandée sur ordinateur et tablette EPUB : format de texte repositionnable ; lecture sur tous supports (ordinateur, tablette, smartphone, liseuse)
DRM Adobe LCP
LCP DRM Adobe
This ebook is DRM protected.
LCP system provides a simplified access to ebooks: an activation key associated with your customer account allows you to open them immediately.
ebooks downloaded with LCP system can be read on:
Adobe DRM associates a file with a personal account (Adobe ID). Once your reading device is activated with your Adobe ID, your ebook can be opened with any compatible reading application.
ebooks downloaded with Adobe DRM can be read on:
mobile-and-tablet To check the compatibility with your devices,see help page
Dr. Raghvendra Ashok Bohara MSc, PhD is a Senior Scientist at CrannMed Ltd., Galway, Ireland, where he leads research and development in biomaterials and embolization medical devices. He previously held prestigious fellowships including the Irish Research Council Postdoctoral Fellowship, the Science Foundation Ireland Fellowship at the University of Galway, and the Indian Council of Medical Research Postdoctoral Fellowship in India. Dr. Bohara’s research bridges nanobiotechnology, biomaterials, and cancer drug delivery, with a strong focus on magnetic-triggered systems and cancer nanomedicine. He has authored more than 70 international peer-reviewed publications, and over 80 in total, along with three books and thirteen book chapters, and holds two patents. His work has been cited over ~5000 times (4,075 in the last five years), with an H-index of 38, placing him among the world’s top 2% scientists for three consecutive years.
A bridge between academia and industry, Dr. Bohara combines translational research with product-driven innovation. He has mentored numerous Master’s and doctoral researchers, actively fostering the next generation of scientists at the interface of academic discovery and industrial application. Beyond his scientific contributions, he serves as Managing Editor for Biomaterials (Elsevier), Associate Editor for Frontiers in Biomaterials Science, and sits on editorial boards of leading journals including Materials Today Bio, Discover Nano, and Scientific Reports . He has also edited volumes with Elsevier, Springer Nature, and IOP Publishing. Dr. Bohara’s achievements have been recognized with the Royal Society of Chemistry Highly Cited Author distinction, the Excellence in Research Award (D.Y. Patil University, India), and multiple Young Scientist Travel Fellowships. His career reflects an unwavering commitment to advancing healthcare solutions, mentoring future researchers, and contributing to the global scientific community.
Sign up to get our latest ebook recommendations and special offers